Financhill
Buy
68

NHI Quote, Financials, Valuation and Earnings

Last price:
$78.95
Seasonality move :
3.84%
Day range:
$78.69 - $79.82
52-week range:
$65.13 - $80.56
Dividend yield:
4.59%
P/E ratio:
24.85x
P/S ratio:
10.22x
P/B ratio:
2.54x
Volume:
219.2K
Avg. volume:
185.7K
1-year change:
3.79%
Market cap:
$3.8B
Revenue:
$338.1M
EPS (TTM):
$3.17

Analysts' Opinion

  • Consensus Rating
    National Health Investors, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $85.00, National Health Investors, Inc. has an estimated upside of 7.8% from its current price of $78.85.
  • Price Target Downside
    According to analysts, the lowest downside price target is $77.00 representing 2.35% downside risk from its current price of $78.85.

Fair Value

  • According to the consensus of 8 analysts, National Health Investors, Inc. has 7.8% upside to fair value with a price target of $85.00 per share.

NHI vs. S&P 500

  • Over the past 5 trading days, National Health Investors, Inc. has underperformed the S&P 500 by -0.71% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • National Health Investors, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • National Health Investors, Inc. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter National Health Investors, Inc. reported revenues of $90.6M.

Earnings Growth

  • National Health Investors, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter National Health Investors, Inc. reported earnings per share of $0.69.
Enterprise value:
4.8B
EV / Invested capital:
1.84x
Price / LTM sales:
10.22x
EV / EBIT:
24.94x
EV / Revenue:
13.39x
PEG ratio (5yr expected):
2.72x
EV / Free cash flow:
22.59x
Price / Operating cash flow:
17.23x
Enterprise value / EBITDA:
17.56x
Gross Profit (TTM):
$218.1M
Return On Assets:
5.5%
Net Income Margin (TTM):
40.67%
Return On Equity:
10.31%
Return On Invested Capital:
5.67%
Operating Margin:
48.82%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $312.9M $331.8M $358.5M $83.7M $90.6M
Gross Profit $190.5M $206.4M $218.1M $51.6M $50.8M
Operating Income $170.7M $186.2M $192.5M $46.8M $44.2M
EBITDA $242.7M $258.9M $273.4M $65.2M $65.2M
Diluted EPS $2.43 $2.91 $3.17 $0.65 $0.69
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $450.3M $350.5M $354M $340.1M $381.2M
Total Assets $2.9B $2.5B $2.5B $2.5B $2.7B
Current Liabilities $71.1M $62.1M $118.5M $72.2M $253.5M
Total Liabilities $1.4B $1.2B $1.2B $1.2B $1.2B
Total Equity $1.5B $1.3B $1.3B $1.2B $1.5B
Total Debt $1.3B $1.1B $1.1B $1.1B $1.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $180.1M $204.3M $228.4M $48.6M $62.6M
Cash From Investing -$62.7M -$29.6M -$243.9M -$1.6M $41.8M
Cash From Financing -$130.6M -$175.5M $79.4M -$46.2M -$42.1M
Free Cash Flow $174.1M $192.4M $212.5M $44M $57.6M
NHI
Sector
Market Cap
$3.8B
$991.9M
Price % of 52-Week High
97.88%
85.05%
Dividend Yield
4.59%
2.45%
Shareholder Yield
-2.63%
3.09%
1-Year Price Total Return
3.79%
-5.22%
Beta (5-Year)
0.677
0.644
Dividend yield:
4.59%
Annualized payout:
$3.60
Payout ratio:
133.53%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $78.93
200-day SMA
Buy
Level $74.42
Bollinger Bands (100)
Buy
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Buy
Level $77.77
Relative Strength Index (RSI14)
Buy
Level 59.98
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -34.0771
50-day SMA
Buy
Level $76.67
MACD (12, 26)
Buy
Level 0.79
25-day Aroon Oscillator
Buy
Level 80
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7099)
Buy
CA Score (Annual)
Level (-0.0168)
Buy
Beneish M-Score (Annual)
Level (-3.3065)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.2733)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities. The SHOP segment is involved in two ventures that own the operations of independent living facilities. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.

Stock Forecast FAQ

In the current month, NHI has received 6 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NHI average analyst price target in the past 3 months is $85.00.

  • Where Will National Health Investors, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that National Health Investors, Inc. share price will rise to $85.00 per share over the next 12 months.

  • What Do Analysts Say About National Health Investors, Inc.?

    Analysts are divided on their view about National Health Investors, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that National Health Investors, Inc. is a Sell and believe this share price will drop from its current level to $77.00.

  • What Is National Health Investors, Inc.'s Price Target?

    The price target for National Health Investors, Inc. over the next 1-year time period is forecast to be $85.00 according to 8 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is NHI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for National Health Investors, Inc. is a Buy. 6 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of NHI?

    You can purchase shares of National Health Investors, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase National Health Investors, Inc. shares.

  • What Is The National Health Investors, Inc. Share Price Today?

    National Health Investors, Inc. was last trading at $78.95 per share. This represents the most recent stock quote for National Health Investors, Inc.. Yesterday, National Health Investors, Inc. closed at $78.85 per share.

  • How To Buy National Health Investors, Inc. Stock Online?

    In order to purchase National Health Investors, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock